Parkinson's Disease News and Research

Latest Parkinson's Disease News and Research

MIT biochemist joins Thomson Reuters’ annual ‘Top 12’ list

MIT biochemist joins Thomson Reuters’ annual ‘Top 12’ list

A guide on ethics and neuroscience

A guide on ethics and neuroscience

UCL scientists explore decision-making process of human brain

UCL scientists explore decision-making process of human brain

Neurologix receives US PTO Notice of Allowance concerning treatment approach for epilepsy

Neurologix receives US PTO Notice of Allowance concerning treatment approach for epilepsy

New study finds green tea extract may prevent Alzheimer's disease and dementia

New study finds green tea extract may prevent Alzheimer's disease and dementia

AED Vimpat demonstrates fewer partial-onset seizures in adults with epilepsy

AED Vimpat demonstrates fewer partial-onset seizures in adults with epilepsy

Study shows experimental thyroid drug reduces cholesterol

Study shows experimental thyroid drug reduces cholesterol

Phase III clinical study: Vimpat demonstrates fewer partial-onset seizures versus placebo in adults with epilepsy

Phase III clinical study: Vimpat demonstrates fewer partial-onset seizures versus placebo in adults with epilepsy

Collaborative center established to reduce obesity-related deaths in African-American and Latino communities

Collaborative center established to reduce obesity-related deaths in African-American and Latino communities

Safeguard Scientifics' aggregate partner company revenue rises 46% in 2009

Safeguard Scientifics' aggregate partner company revenue rises 46% in 2009

Study shows smokers have lower risk of developing Parkinson's disease

Study shows smokers have lower risk of developing Parkinson's disease

Sleep disorders may increase risk of cardiovascular and metabolic diseases

Sleep disorders may increase risk of cardiovascular and metabolic diseases

Ampicillin activates torsinA, improves cell function to reduce movement disorders

Ampicillin activates torsinA, improves cell function to reduce movement disorders

Chelsea Therapeutics announces financial results for fourth quarter 2009

Chelsea Therapeutics announces financial results for fourth quarter 2009

NeuroSearch's MermaiHD study supports potential Huntington's disease modifying properties of Huntexil

NeuroSearch's MermaiHD study supports potential Huntington's disease modifying properties of Huntexil

Children's Hospital Boston develops new web site, releases video message on current state of stem cell research

Children's Hospital Boston develops new web site, releases video message on current state of stem cell research

AMT initiates dosing in Phase I/II gene therapy clinical trial for hemophilia B

AMT initiates dosing in Phase I/II gene therapy clinical trial for hemophilia B

Diamyd Medical enrolls over 430 children with newly diagnosed type 1 diabetes in global Phase III program

Diamyd Medical enrolls over 430 children with newly diagnosed type 1 diabetes in global Phase III program

2010 European LDN Conference: LDN can be used as effective treatment for people with MS

2010 European LDN Conference: LDN can be used as effective treatment for people with MS

Omeros obtains exclusive license to compounds from Asubio Pharma for use in its PDE7 program

Omeros obtains exclusive license to compounds from Asubio Pharma for use in its PDE7 program

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.